RIO DE JANEIRO, BRAZIL - India’s Bharat Biotech has signed an agreement with a medicine distributor to supply its COVID-19 vaccine to Brazil, it said on Tuesday, January 12th, even as the shot’s emergency use approval in its home country has faced criticism.
India’s drug regulator has given emergency use approval to Bharat Biotech’s COVAXIN, as well as to AstraZeneca and Oxford University’s Covishield vaccine, which is being produced by the Serum Institute of India.
Bharat Biotech said it has signed an agreement with a Brazil-based pharmaceutical seller, Precisa Medicamentos, to supply COVAXIN.
“It . . .